Wyeth Premarin Plan For 2002: Stabilize Rxs Ahead Of Low-Dose Launch

Wyeth-Ayerst believes it can continue to grow the Premarin franchise in 2002 despite another delay in the projected launch date for a low-dose formulation of the conjugated estrogen/progestin combo Prempro.